Cite

HARVARD Citation

    Coutre, S. et al. (n.d.). FIRST‐LINE TREATMENT WITH IBRUTINIB FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): 7‐YEAR RESULTS FROM RESONATE‐2. Hematological oncology. p. n/a. [Online]. 
  
Back to record